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The pneumococcus is an important Gram-positive pathogen, which shows
increasing resistance to antibiotics, including b-lactams that target peptido-
glycan assembly. Understanding cell-wall synthesis, at the molecular and
cellular level, is essential for the prospect of combating drug resistance. As
a ﬁrst step towards reconstituting pneumococcal cell-wall assembly in vitro,
we present the characterization of the glycosyltransferase activity of penicil-
lin-binding protein (PBP)2a from Streptococcus pneumoniae. Recombinant
full-length membrane-anchored PBP2a was puriﬁed by ion-exchange chro-
matography. The glycosyltransferase activity of this enzyme was found to
differ from that of a truncated periplasmic form. The full-length protein
with its cytoplasmic and transmembrane segment synthesizes longer glycan
chains than the shorter form. The transpeptidase active site was functional,
as shown by its reactivity towards bocillin and the catalysis of the hydroly-
sis of a thiol-ester substrate analogue. However, PBP2a did not cross-link
the peptide stems of glycan chains in vitro. The absence of transpeptidase
activity indicates that an essential component is missing from the in vitro
system.
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Introduction
Penicillin-binding proteins (PBPs) are enzymes that
assemble the peptidoglycan on the external face of the
plasma membrane of bacteria [1]. The inhibition of
PBPs by b-lactams (such as penicillin) leads to growth
arrest or cell death. Nowadays, strains of several impor-
tant pathogens such as Staphylococcus aureus, Entero-
coccus faecium, Neisseria meningitidis or Streptococcus
pneumoniae resist b-lactams by expressing PBPs that
react poorly with the drugs [2]. These ‘low-afﬁnity’
PBPs remain physiologically efﬁcient in building the
cell wall, despite the fact that b-lactams, for which
they have lost their reactivity, are structural mimics of
the natural substrate. To solve this paradox, we need
now to study the reactions of peptidoglycan assembly.
Abbreviations
CMC, critical micellar concentration; DDM, n-dodecyl-b-D-maltopyranoside; EGS, ethylene glycol bis(succinic acid N-hydroxysuccinimide
ester); GT, glycosyltransferase or transglycosylase; MurNAc, N-acetylmuramic acid; PBP, penicillin-binding protein; TP, transpeptidase;
b-OG, n-octyl-b-D-glucopyranoside.
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It is our long-term objective to reconstitute in vitro the
formation of the cell wall of the pneumococcus. As an
important step towards this aim, we report here a
characterization of full-length PBP2a from S. pneumo-
niae, following a previous study of a truncated form
[3,4].
Peptidoglycan is the major component of the bacte-
rial cell wall, which maintains cell shape, resists intra-
cellular pressure and acts as a platform for anchored
macromolecules such as proteins and polysaccharides
[5–7]. This macromolecular network is made of glycan
chains of alternating N-acetylglucosamine and N-acetyl-
muramic acid (MurNAc) that are cross-linked by short
peptides attached to the MurNAc [7]. The peptidogly-
can is polymerized from a precursor (lipid II) that is
synthesized in the cytoplasm and ﬂipped to the outer
face of the plasma membrane [8,9]. PBPs catalyze the
polymerization of glycan chains (transglycosylation)
and the peptidic cross-linking of glycans strands
(transpeptidation).
PBPs have been divided into three classes [1]. Class
A PBPs are bifunctional with both glycosyltransferase
(GT) and transpeptidase (TP) activity. Class B PBPs
have only one identiﬁed catalytic domain with poten-
tial TP activity. Class C PBPs have hydrolytic activities
and participate in peptidoglycan maturation and cell
separation. The domain with hydrolytic or TP activity
is the target of b-lactams. The enzymatic GT activity
of the class A PBPs constitutes a promising alternative
target. Moenomycin is the principal antibiotic directed
against GT activity. However, because of poor phar-
macokinetic properties and oral bioavailability, moe-
nomycin is not used in human clinical therapy [10].
In recent years, important advances have been made
in both structural and functional studies of class A
PBPs. The crystal structure of several PBP GTases are
now available: the extracellular domain of PBP2 from
Staphylococcus aureus [11,12], the GT module of
PBP1a from Aquifex aeolicus [13,14] and the full-length
PBP1b from Escherichia coli [15]. In parallel, impor-
tant advances have been made in the synthesis of
lipid II [16–20], enabling characterization of the GT
activity of a number of proteins. To date, more than
10 bacterial GT proteins have been puriﬁed and char-
acterized including the periplasmic form of PBP2a and
PBP1a from S. pneumoniae [1,21]. In particular, the
direction of glycan chain elongation has been eluci-
dated, involving successive attacks of the growing
chain (donor) at the reducing end of the lipid II
(acceptor) [22,23]. Also, different enzymes produce
chains with different length distribution [24]. Screening
methods for the identiﬁcation of GTase inhibitors have
been proposed [25–28].
In this work with pneumococcal PBP2a, we found
that the transmembrane segment inﬂuences the length
of the polymerized glycan chains. We could not detect
TP activity, despite the fact that the puriﬁed protein
reacted with a b-lactam, indicating that the TP active
site was functional.
Results and Discussion
Purification of full-length and truncated
periplasmic PBP2a
First, full-length PBP2a was expressed in E. coli with
various N-terminal afﬁnity tags (poly-histidine, cal-
modulin-binding peptide or Strep-tag). Isolated mem-
branes were solubilized in Triton X-100 and the tagged
proteins were puriﬁed on the corresponding afﬁnity
resins. None of the tagged PBP2a displayed GT acti-
vity (data not shown).
We hypothesized that the tags or the linker (formed
mostly by a TEV protease cleavage site) could interfere
with the activity. We therefore attempted to purify
untagged full-length PBP2a by ion-exchange chroma-
tography. We applied successively cation- and anion-
exchange chromatography, and to our surprise, PBP2a
bound to both types of resin (SP-Sepharose and
Resource Q) at nearly the same pH, pH 8 for the
cation-exchange and pH 7.5 for the anion-exchange
chromatography. In both cases, PBP2a was eluted with
 300 mM of NaCl. This unexpected behavior allowed
puriﬁcation to near homogeneity in two steps
(Fig. 1A). The yield was  0.5 mg proteinÆL culture)1.
The overall predicted isoelectric point (pI) of PBP2a
is 6.0, with a net negative charge of -8 at pH 7.5–8.
The retention of PBP2a on a strong cation-exchange
medium is thus unexpected. However, a closer exam-
ination of the sequence reveals that the cytoplasmic
region (residues 1–56) has a pI of 10.3 and a net
positive charge of +7 at pH 8, whereas the extracel-
lular region (residues 78–731) has a pI of 5.3 and a
net negative charge of )16 at pH 7.5. This charge
distribution is expected from the ‘positive inside’
rule that deﬁnes the transmembrane orientation of
membrane proteins [29]. We suggest that the two
parts of the solubilized proteins are isolated from
each other by the detergent micelle around the
transmembrane segment, and that this particular
arrangement may allow binding to the cation-
exchanger by the cytoplasmic part, and to the
anion-exchanger by the periplasmic domains. It
would be of interest to test whether this behavior is
general for bitopic membrane proteins that have a
similar charge distribution.
Glycosyltransferase activity of pneumococcal PBP2a N. Helassa et al.
2072 FEBS Journal 279 (2012) 2071–2081 ª 2012 The Authors Journal compilation ª 2012 FEBS
The periplasmic region of S. pneumoniae PBP2a
(PBP2a*) was prepared as described previously [4],
with an additional anion-exchange chromatography
following cleavage of the glutathione S-transferase-tag
(Fig. 1A). This last step eliminated minor contaminants
and allowed to exchange the detergent from Chaps
to Triton X-100. The yield was  2 mg proteinÆL
culture)1.
N-Terminal sequencing yielded the expected
sequence for both PBP2a and PBP2a*, and electro-
spray MS conﬁrmed the integrity of both proteins
(PBP2a: 80 797 ± 2 Da measured vs 80 799 expected;
PBP2a*: 73 810 ± 2 measured vs 73 812 expected).
The TP domains of the full-length and truncated vari-
ants were functional for the reaction with the ﬂuores-
cent penicillin bocillin (Fig. 1A).
Limited proteolysis of PBP2a and PBP2a* with tryp-
sin produced a common major protein fragment with
an apparent molecular mass of 44 kDa (Fig. 1B).
N-Terminal sequencing showed that this fragment starts
at residue 264 and thus comprises the TP domain. This
main trypsin-resistant domain had been identiﬁed pre-
viously in PBP2a* [4]. Mass spectrometry of this frag-
ment had revealed that it consisted of residues 264–678
[4]. The shorter minor tryptic fragment, which also
appears with both PBP2a and PBP2a*, had been
found in the previous study of PBP2a* to encompass
residues 301–678 [4]. The GT domain in full-length
PBP2a is therefore susceptible to tryptic digestion, as
in the truncated form. However, greater amounts of
trypsin seem to be required to digest full-length
PBP2a, indicating that the presence of the transmem-
brane and cytoplasmic regions may stabilize the GT
domain to some extent, at least in the presence of
detergent.
The oligomeric state of PBP2a was probed by chem-
ical cross-linking followed by SDS ⁄PAGE. Following
incubation with the cross-linking agent [ethylene glycol
bis(succinic acid) N-hydroxysuccinimide ester; EGS],
additional bands were observed in the case of PBP2a,
but not with PBP2a* (Fig. 1C). The apparent mass of
the main species is consistent with the presence of a
dimer ( 150 kDa). The presence of species with
higher masses hints at the presence of higher orders
oligomers or aggregates. The absence of cross-linking
of PBP2a* by EGS (Fig. 1C) suggests that the self-
association of PBP2a may depend on its transmem-
brane and ⁄or cytoplasmic regions.
Size-exclusion chromatography in the presence of
0.02% Triton X-100 did not show the presence of
aggregates with either PBP2a or PBP2a* (not shown).
The presence of Triton X-100, which absorbs at
280 nm, precluded the monitoring by UV absorbance;
instead, elution fractions were analyzed by
SDS ⁄PAGE. Both the full-length and truncated forms
were eluted with comparable volumes of solution, cor-
responding to an apparent molecular mass of globular
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Fig. 1. Characterization of PBP2a and PBP2a*. (A) Coomassie Bril-
liant Blue- and bocillin-stained SDS ⁄ PAGE analysis of recombinant
PBP2a and PBP2a*, following SP-Sepharose (SP) or Resource Q
(RQ) chromatography. M is for solubilized E. coli membranes prior
to chromatography. Boc is for bocillin. The Boc lanes were imaged
under UV illumination from the same gels prior to Coomassie Bril-
liant Blue staining. The asterisk signals that 25% dimethylsulfoxide
was present during the reaction with bocillin. (B) Partial tryptic
proteolysis of PBP2a and PBP2a* analyzed by Coomassie Brilliant
Blue-stained SDS ⁄ PAGE. (C) Cross-linking in vitro of PBP2a and
PBP2a* with varying amounts of EGS, analyzed by Coomassie
Brilliant Blue-stained SDS ⁄ PAGE.
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proteins comprised between 500 and 300 kDa. It is
unclear why both proteins behave similarly in size-
exclusion chromatography and differently in the cross-
linking reaction. The presence of large micelles of
detergent may mask size differences of the proteins.
The dimerization of PBP1b from E. coli has been
observed by SPR with a dissociation constant KD of
 100 nm [30]. The dimerization was found to stimu-
late the GT activity of E. coli PBP1b and to be neces-
sary for its TP activity [30]. The oligomerization of
class A PBPs has also been observed in vivo [31,32].
Optimization of GT reaction conditions
Reaction conditions are critical for PBP GT in vitro
activity, for example, the nature of the divalent cation
or the detergent and dimethylsulfoxide concentration
[28,33,34]. Full-length PBP2a was incubated with
labeled ﬂuorescent lipid II in the presence of different
concentrations of dimethylsulfoxide and Triton X-100
detergent. The detergent was either added to a concen-
tration about fourfold its critical micellar concentra-
tion (CMC) in water, or only brought to the reaction
mix with the puriﬁed protein, resulting in a concentra-
tion about ﬁvefold below the CMC. The reaction
products were analyzed by Tris ⁄Tricine SDS ⁄PAGE
[35] (Fig. 2A,B). The lipid II migrates near the front
and appears as dark thick bands at the bottom of the
gel. The polymerized glycan chains appear as a smear
above the lipid II band (see below for a more com-
plete description of the assay). In this small 5-cm-long
gel system, discrete chain lengths were not resolved.
The reaction was optimal with 30–40% dimethylsulf-
oxide. The reaction started to be less efﬁcient with
50% dimethylsulfoxide, as seen by the amount of
unprocessed lipid II remaining after 40 min of reac-
tion. The inhibitory effect of dimethylsulfoxide at high
concentration may be due to denaturation of the
enzyme.
Interestingly, at a high concentration of Triton
X-100, dimethylsulfoxide was required to observe an
activity of PBP2a, whereas at a low detergent concen-
tration, the reaction could occur to some extent in the
absence of dimethylsulfoxide. Thus, dimethylsulfoxide
appears to rescue the GT activity in the presence of
detergent concentrations that are normally inhibitory,
as observed previously with PBP1a from Thermo-
toga maritima and PBP1b from E. coli in decyl-poly
(ethylene glycol) [28,34]. This effect of dimethylsulf-
oxide has been attributed to a greater solubility of the
lipidic substrate and to faster exchange between deter-
gent micelles [34]. Note that the in vitro activity of the
N-acetylglucosminnyl transferase MurG to convert
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Fig. 2. Effect of dimethylsulfoxide and detergent on the GT activity
of PBP2a. (A,B) Effect of the concentration of dimethylsulfoxide on
the GT reaction in the presence of 0.002 and 0.04% Triton X-100,
respectively. Reactions using dansylated lipid II at 30 C were
stopped after 40 min, analyzed by Tris–Tricine SDS ⁄ PAGE and
imaged under UV light. The lane noted with Moe was with 0.5 mM
moenomycin and no dimethylsulfoxide. (C) Comparison of the
effect of different detergents on the reaction followed by the
decrease of fluorescence, using dansylated lipid II as substrate.
See Offant et al. and Schwartz et al. for a description of the assay
[28,34]. All reactions contained 0.02% Triton X-100. Added deter-
gents were: none (black solid line), 1% Chaps (black dotted line),
0.02% DDM (black short dashes), 0.02% Triton X-100 (black long
dashes), 0.25% Cymal-5 (black dot-and-dashed line), 0.08% Cymal-
4 (gray solid line) and 1% b-OG (gray dashes). The gray dotted line
is without enzyme. Cymal-3 was omitted for clarity.
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lipid I into lipid II, the activity was highest with 35%
dimethylsulfoxide in the presence of 0.1% deoxycho-
late [36].
To assess the effect of the nature of the detergent on
the GT activity, we used a continuous ﬂuorescence
assay in a 96-well format [28,34]. In this assay, a modi-
ﬁed lipid II is used, which has a ﬂuorescent dansyl
probe attached to the stem peptide. When glycan
chains are polymerized, the probe is incorporated in
the growing chains. However, a muramidase is present
in the reaction mix that hydrolyzes the chains into
disaccharide pentapeptides, which still harbor the ﬂuo-
rescent probe. Thus, the dansyl probe, which is initially
bound to lipid II, is found in molecules devoid of lipid
moiety as the reaction proceeds. This change of envi-
ronment of the dansyl probe is accompanied by a
decrease of ﬂuorescence.
Detergents were tested at about twice their CMC in
water. We observed no GT activity in the presence of
n-octyl-b-D-glucopyranoside (b-OG), Cymal-3 and
Cymal-4 (Fig. 2C). PBP2a was active in the presence of
Chaps, n-dodecyl-b-D-maltopyranoside (DDM) or Tri-
ton X-100, and less so in Cymal-5. The highest activity
was found with Chaps, Triton X-100 and DDM. In
all cases, we used detergent concentrations above
their CMC in water. The shortest detergents (b-OG,
Cymal-3 and Cymal-4) were not suitable. Because
short detergents have high CMCs, it is possible that
the inhibitory effect results from the decreased proba-
bility that enzyme-containing micelles encounter sub-
strate-containing micelles, as proposed previously [34].
Considering these results, partially presented in Fig. 2,
we chose for further work to use the intermediate
dimethylsulfoxide concentration of 25% and 0.02 or
0.04% of Triton X-100 as detergent.
GT enzymatic activity
We aimed to determine the rate of transglycosylation
catalyzed by PBP2a, PBP2a* and E. coli PBP1b, using
the 96-well microplate assay. Because of substrate limi-
tation, we were not able to measure enough rates to
obtain accurate values of the enzymatic parameters.
However, by measuring the initial rates of lipid II
consumption at two concentrations of lipid II, we
could estimate that the kcat for both PBP2a and
PBP2a* is > 5 · 10)4 s)1. PBP2a* was somewhat more
efﬁcient. The speciﬁc activity measured with 10 lM
dansylated lipid II was 0.38 nmol lipid IIÆmin)1Æmg
enzyme)1 for PBP2a, and slightly faster at 0.5 nmol
lipid IIÆmin)1Æmg enzyme)1 for PBP2a*. For compari-
son, we measured a kcat of (3.0 ± 0.5) 10
)2 s)1 for
E. coli PBP1b. The speciﬁc activity of E. coli PBP1b
was 22.5 nmol lipid IIÆmin)1Æmg enzyme)1. These ﬁnd-
ings are comparable to published values [37].
Full-length PBP2a and PBP2a* showed comparable
speciﬁc activities for the consumption of lipid II, indi-
cating that the membrane anchor does not have an
important effect on this aspect of the enzymatic
activity. The catalytic constant was 104-fold higher
than reported in a previous study of PBP2a* [3], but
still 40–60-fold lower than that of E. coli PBP1b. The
dimerization of E. coli PBP1b was found to promote
GT activity [30]. If this ﬁnding applies to PBP2a, one
factor limiting the activity of PBP2a in vitro might be
a concentration that is below its dissociation constant.
The Tris–Tricine SDS ⁄PAGE assay developed by
Barrett et al. [35] allows the visualization of the
synthesized glycan chains length, using radio-labeled
lipid II as precursor. In this study, we used a ﬂuores-
cently labeled lipid II, with a dansyl group attached on
the third position of the substrate pentapeptide (lysine
amine). This kind of modiﬁcation should not affect the
kinetics parameters of the GT reaction [18,38]. How-
ever, because the lysine amine that bears the dansyl
probe is normally the acceptor group of the transpepti-
dation, no TP activity can occur with this precursor.
Gels were imaged on a UV transilluminator. Lipid II
migrates near the front of the electrophoresis, chains
of disaccharide units migrate more slowly as they are
longer. For short chains, individual bands were
resolved with this 20 cm gel system, up to  10 disac-
charide units. Longer chains were not resolved and
merged in a smear. Some ﬂuorescent material, likely
constituted of longer chains remained in the wells.
Using this assay, we examined the distribution of
products of full-length PBP2a and PBP2a*. We found
that remaining free lipid II could not be detected after
 2 h of reaction (Fig. 3). The lack of resolution of
glycan chains of high molecular mass prevented precise
determination of the chain length. However, by com-
parison with chains assembled by E. coli PBP1b,
known to synthesize chains of 30–50 units [24,28,30],
we estimated that PBP2a produced chains of 20–
30 units. By contrast, PBP2a* produced much smaller
chains of ﬁve to six disaccharides. These results indi-
cate that full-length PBP2a from S. pneumoniae is
more processive than its truncated form PBP2a*.
Because both forms of the enzyme use up lipid II at
similar rates, the different chain lengths that are pro-
duced suggest that PBP2a* starts assembling chains
more easily, but also releases glycan chains more read-
ily than the full-length proteins. This phenomenon
could be due to the transmembrane and ⁄or cytoplas-
mic region directly, or indirectly through the absence
of dimerization of PBP2a*. Interestingly, the absence
N. Helassa et al. Glycosyltransferase activity of pneumococcal PBP2a
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of the transmembrane segment of E. coli PBP1b was
found to decrease ﬁvefold the afﬁnity for the drug
moenomycin [25]. Examination of the structure of
E. coli PBP1b, the sole structure of a full-length class
A PBP, led Sung et al. to propose that removal of the
transmembrane segment would impact on the binding
of lipid II and moenomycin [15]. Alternatively, an indi-
rect effect of the detergent micelle surrounding the
hydrophobic transmembrane segment could change the
dynamics of the enzyme–substrate–product interactions.
A former comparative study of several PBPs from
different organisms showed that PBP2a from Entero-
coccus faecalis and PBP2 from Staphylococcus aureus
produced chains of only 15 units. PBP1a from E. coli
made longer chains than PBP1b from the same bacte-
ria. The glycan chain length was not dependent on the
enzyme-to-substrate ratio [24].
Some studies have reported a delay in the onset of
the reaction catalyzed by E. coli PBP1b, which has
been attributed either to a slow initial coupling step or
to a slow rearrangement to the active conformation
[34,39]. This lag phase has not been observed with
PBP2a from S. pneumoniae (Fig. 3C). Note that in
Fig. 3A,B, the images were overexposed to better visu-
alize the glycan chains. This caused most of the lipid II
bands to be saturated and to not reﬂect their actual
amount. For the quantiﬁcation shown in Fig. 3C, a
shorter exposure was used, which revealed the concom-
itant disappearance of lipid II with the appearance of
the glycan chains. The short exposure image is not
shown as the glycan chains are then barely visible,
although the amount of ﬂuorescence integrated over
the length of the gel remains constant.
Absence of TP activity in vitro
The TP assay was based on the SDS ⁄PAGE assay, but
using a mix of ﬂuorescent (for detection) and nonﬂuo-
rescent lipid II (for cross-linking). Pure labeled lipid II
cannot be used to investigate the TP activity, because
it cannot serve as an acceptor in the reaction. Indeed,
the ﬂuorescent probe is attached to the third residue-
free amine that participates in the reaction. By using
95% of unlabeled and 5% ﬂuorescent lipid II, we
hoped to allow transpeptidation to occur, while incor-
porating enough labeled material to visualize the
products after SDS ⁄PAGE. The experimental setup
was validated using E. coli PBP1b, which is known to
display both GT and TP activities in vitro [30,40]. In
the absence of b-lactam, using a mixture of lysine-
dansylated (5%, 10 lM) and meso-diaminopimelate-
containing lipid II (95%, 200 lM), E. coli PBP1b
(0.5 lM) generated in 2 h a ﬂuorescent product of high
molecular mass that was retained on the top of the
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Fig. 3. GT activity using dansylated lipid II, monitored by Tris–Tricine SDS ⁄ PAGE and imaged under UV light. (A) Comparison of the chain
length distribution resulting from the activity of PBP2a and PBP2a*. As a positive control, a reaction catalyzed by E. coli PBP1b was
included. As negative control, a PBP2a variant with the active site residue replaced E131Q was used. The last lane demonstrates the
absence of effect of penicillin (Pen) on the GT activity. Reaction times are given below the lanes. (B) Kinetics of the polymerization of glycan
chains by PBP2a, as in (A) with more time points. (C) The fluorescence in the lipid II band (•), the glycan chains smear ( ) and the well ( )
were quantified and represented on the graph.
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polyacrylamide gel (Fig. 4). We used meso-diamino-
pimelate-containing lipid II, the natural precursor of
E. coli peptidoglycan, because PBP1b does not catalyze
transpeptidation with lysine-containing precursors (W.
Vollmer, unpublished). In the presence of penicillin,
E. coli PBP1b produced glycan chains of the expected
size, demonstrating that the large polymer obtained in
the absence of penicillin resulted from transpeptida-
tion. Under the same experimental conditions, using
lysine-containing lipid II, PBP2a did not display trans-
peptidase activity, even with 10 times higher concentra-
tion of enzyme after 5 h.
Despite the absence of detectable transpeptidase
activity of PBP2a and PBP2a*, both variants reacted
with bocillin (Fig. 1A), and both catalyzed the hydro-
lysis of S2d, a thiol-ester analogue of the stem peptide.
Hydrolysis of thiol-ester analogues has been used tra-
ditionally as a proxy for the TP activity in the absence
of physiologically relevant substrate [41]. Values given
in Table 1 show that the activity of the pneumococcal
PBPs is on par with that of E. coli PBP1b with respect
to S2d hydrolysis. This observation raises the question
of the absence of transpeptidase activity.
One trivial explanation would have been that the
DMSO required for optimal GT activity is inhibiting
the TP activity. However, we showed that reaction
with bocillin is not hampered by 25% DMSO
(Fig. 1A, * lanes). Conversely, because we found that
PBP2a exhibits some residual GT activity in the
absence of DMSO at low a concentration of Triton
X-100, we repeated the assay under these conditions
(no DMSO, 0.002% Triton X-100) but did not observe
TP activity (not shown).
To our knowledge, no transpeptidation catalyzed by
puriﬁed PBPs from Gram-positive organisms has ever
been reported. Early experiments with enzymes from
Bacillus species showed that although GT activity was
observed, no transpeptidation occurred with PBPs
from Bacillus subtilis, and only minor amount with
PBPs from Bacillus stearothermophilus [42]. It is possi-
ble that the assembly of a thick peptidoglycan depends
on a more controlled activity of the PBPs interacting
with activating factors, and that isolated pneumococcal
PBPs are inactive. Activators of peptidoglycan assem-
bly are known in some Gram-negative species [43,44].
An alternative hypothesis is that the lipid II used in
our study is not the proper substrate for PBP2a or for
pneumococcal PBPs in general. The peptidoglycan of
pneumococcus contains a signiﬁcant fraction of
‘branched’ muro-peptides. In those, a Ser–Ala or Ala–
Ala dipeptide is added onto the side chain of the third
residue lysine. Cross-linking by transpeptidation then
occurs through the free amine of the Ala. The presence
of these branched peptides is necessary for the expres-
sion of b-lactam resistance [45]. It is conceivable that
the TP domain of PBP2a is specialized for branched
peptides. Also, the lysine-containing lipid II used in
our study contains a glutamate as second residue of
the stem peptide [16]. In most Gram-positive bacteria,
the second residue is an iso-glutamine that results from
the amidation of the glutamate by the recently identi-
ﬁed essential amidotransferase MurT ⁄GatD [46,47].
Depletion of the MutT ⁄GatD amido transferase
impairs growth and increases the susceptibility of
Staphylococcus aureus to b-lactams. These observations
suggested that one or more staphylococcal PBPs may
require or prefer amidated lipid II [46,47]. This modiﬁ-
cation occurs at the stage of the lipid II, as shown in
early studies with particulate extracts from Staphylo-
coccus aureus [48]. Finally, the correct substrate for
Table 1. S2d hydrolysis activity. The specific activity measured
with 2 mM S2d.
Protein
Specific activity
(nmolÆmin)1Æmg enzyme)1)
PBP2x 1058
PBP2x* 1884
PBP2a 403
PBP2a* 964
E. coli PBP1b 432
Lipid II
Peptidoglycan
Glycan chains
Moe Pen
Fig. 4. Assembly of peptidoglycan in vitro by E. coli PBP1b moni-
tored by Tris–Tricine SDS ⁄ PAGE. Reactions were carried out with a
mixture of dansylated lipid II (5%) and unlabeled meso-diamino-
pimelate-containing lipid II, without and with moenomycin (Moe) or
penicillin G (Pen). Cross-linked peptidoglycan does not enter de gel
system and remains trapped at the level of the loading well.
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PBP2a-catalyzed transpeptidation, at least as acceptor,
might be the pre-existing peptidoglycan itself.
In conclusion, we aimed to purify and to character-
ize recombinant full-length and periplasmic PBP2a
from S. pneumoniae, in order to reconstitute in vitro
the peptidoglycan synthesis from this important
Gram-positive pathogen. We found that the GT
activity of PBP2a was very sensitive to the reaction
conditions such as the concentration of DMSO and
the detergent. Also, we observed that membrane
anchor inﬂuences glycan chain length in vitro. The
next challenge will be to demonstrate TP activities
from pneumococcal PBPs, as it has never been
obtained with recombinant enzymes from Gram-posi-
tive organisms.
Experimental procedures
Materials
Triton X-100 and Chaps were purchased from Euromedex
(Souffelweyersheim, France); DDM; b-OG, Cymal-3,
Cymal-4 and Cymal-5 were from Anatrace (Maumee, OH,
USA). Moenomycin was a gift from Aventis (Frankfurt am
Main, Germany). The thio-ester substrate S2d (N-benzoyl-
D-alanylmercaptoacetic acid) was obtained from B. Joris
(Centre d’Inge´nierie des Prote´ines, Universite´ de Lie`ge,
Belgium). Lipid II (with Ala-D-iGlu-Lys-D-Ala-D-Ala) was
obtained from University of Warwick, UK-BaCWAN syn-
thetic facility [49]. Lysine-dansylated lipid II was prepared
as described previously [16], with the modiﬁcation that the
lysine was dansylated by incubation of UDP-MurNAc-pen-
tapeptide (22 mg) with dansyl chloride (25 mg) in 20 mL of
dimethyl formamide 50%, N,N-diisopropylethylamine
0.5%, for 3 h at room temperature.
Plasmids for expression of pneumococcal PBP2a
and PBP2x
The pbp2a gene was ampliﬁed from R6 S. pneumoniae
genomic DNA by PCR with the primers GAGAATTCC
ATATGAAATTAGATAAATTATTTGAG and GGTC
GACGGATCCACTAGTGCTAGCTTAGCGAAATAGA
TTG, and introduced as a NdeI–BamHI fragement into
pET-30b, to express full-length PBP2a. The plasmid used to
express the truncated PBP2a* was that described previously
[4]. The plasmid for the expression of the PBP2a–E131Q
mutant was constructed using the primers GCAGAATG
CTGTTATCGCGACACAGGACCGTTCTTTC and its
reverse complement, with the Quickchange kit (Stratagene,
Santa Clara, CA, USA).
The pbp2x gene was ampliﬁed using the primers GAG
AATTCCATATGAAGTGGACAAAAAGAGTAATC and
GGTCGACGGATCCGTCTCCTAAAGTTAATG, and
introduced as a NdeI–BamHI fragment into a modiﬁed
pET-30b vector (A. Zapun, unpublished) that allows
expression of proteins with a C-terminal Strep-tag.
Production and purification of PBPs
Full-length PBP2a or PBP2x–Strep were overexpressed in
E. coli BL21(DE3) cells (Invitrogen, Paisley, UK). Cells
were grown at 37 C in 2 L of Luria–Bertani broth supple-
mented with kanamycin to D600 = 2 and expression was
induced overnight at 20 C in the presence of 1 mM isopro-
pyl thio-b-D-galactside. Cells were resuspended in 40 mL of
lysis buffer (50 mM Hepes, pH 7.5, 500 mM NaCl, 10 mM
MgCl2) containing one tablet of Complete protease inhibi-
tor cocktail (Roche, Basel, Switzerland). Cells were broken
in a Microﬂuidizer (Microﬂuidics, Newton, MA, USA) at
10 000 psi. Membranes were sedimented by ultracentrifu-
gation (150 000 g, 1 h, 4 C). The pellet was resuspended in
10–20 mL of lysis buffer to reach D600 = 1, and mem-
branes were solubilized with Triton X-100 1% for 30 min
at 4 C.
Full-length PBP2a was puriﬁed by two chromatography
steps performed at 4 C. Solubilized membranes were
loaded onto a cation exchange 5 mL SP-Sepharose column
(GE Healthcare, Chalfont St Giles, UK) equilibrated with
50 mM Tris pH 8.0, 10 mM MgCl2, containing 0.2%
Triton X-100. Bound proteins were eluted with a 0–1 M
NaCl gradient over 10 column volumes. Pooled fractions
containing PBP2a were diluted 10-fold and loaded onto a
6 mL Resource Q column (GE Healthcare) equilibrated
with 50 mM Hepes pH 7.5, 10 mM MgCl2, containing 0.2%
Triton X-100. The PBP2a–E131Q mutant was prepared
in the same manner. PBP2a* and the membrane-bound
c-isoform (46–844) PBP1b from E. coli were prepared as
described previously [4,30].
PBP2x–Strep was puriﬁed by a single afﬁnity chromato-
graphy step. Solubilized membranes were incubated for
1 h with 0.5 mL of Strep-Tactin Superﬂow resin (IBA,
Go¨ttingen, Germany) equilibrated with the lysis buffer
containing 0.02% DDM. After washing with 8 column
volumes, the protein was eluted with the same buffer con-
taining 2.5 mM desthiobiotin. The truncated periplasmic
PBP2x* was prepared as described previously [50].
Protein characterization
The protein concentration was measured using the BCA
protein assay kit (Pierce, Rockford, IL, USA) using BSA as
a standard. Size-exclusion chromatography was performed
on a S200 Superdex GL 5 ⁄ 150 column (GE Healthcare) in
50 mM Hepes, pH 7.5, 150 mM NaCl, 10 mM MgCl2 and
0.02% Triton X-100. Cross-linking in vitro was performed
with EGS in the same buffer. Full-length PBP2a or PBP2a*
(1.4 lM) were incubated for 20 min with 0–0.4 mM of EGS
(Sigma-Aldrich, St Louis, MO, USA). After reaction
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quenching by the addition of 50 mM Tris (pH 8.0) for
15 min, samples were analyzed by SDS ⁄PAGE and western
blot with rabbit anti-PBP2a serum. Limited proteolysis was
performed on 6 mgÆmL)1 of PBPs, with trypsin ⁄PBP ratios
ranging from 1 : 105 to 1 : 102 (w ⁄w). After incubation for
30 min at 37 C, protease activity was inhibited with 1 mM
phenylmethanesulfonyl ﬂuoride and the proteolyzed sam-
ples were analyzed by SDS ⁄PAGE (30 lg PBPÆlane)1).
GT and TP activity assays
To determine the optimal concentration of DMSO, PBP2a
(2 lM) was incubated for 40 min with lysine-dansylated
lipid II (25 lM) at 30 C, in 50 mM Hepes pH 7.5, 200 mM
NaCl, 25 mM MgCl2 and various concentrations of DMSO
(0 to 50%), with Triton X-100 (0.002%, brought by the
protein preparation, or 0.04%). The reactions were stopped
after 40 min by the addition 0.5 mM moenomycin. Samples
were analyzed by Tris–Tricine SDS ⁄PAGE [35] and gels
were imaged on a UV (302 nm) transilluminator using a
Gel Doc system (Bio-Rad, Hercules, CA, USA).
For glycan chain length determination, conditions were
as above except that the reaction mixtures contained 1 lM
PBP2a, 10 lM of lysine-dansylated lipid II, 25% DMSO
and 0.04% Triton X-100. After various time intervals (0–
7 h), reactions were stopped with 0.5 mM moenomycin.
Samples were analyzed as above, bands were quantiﬁed
using IMAGEJ software.
The same Tris–Tricine SDS ⁄PAGE assay was used to
demonstrate TP activity. However, a mixture of 10 lM
dansylated and 200 lM unlabeled lipid II (meso-diamino-
pimelate-containing lipid II with E. coli PBP1b) was used,
in order to provide the free amine on the third residue that
is necessary to function as acceptor in the transpeptidation
reaction. The concentration of E. coli PBP1b was 0.5 lM,
for an incubation time of 2 h at 30 C. With PBP2a,
attempts were made with protein concentrations up to 6 lM
and incubation times as long as 5 h.
The continuous ﬂuorescent assay in a 96-well format was
used to compare the effect of detergents and the GT kine-
tics of different PBPs [28,34]. The reaction mix (50 lL)
included lysine-dansylated lipid II (10 lM) in 50 mM Hepes,
pH 7.5, 200 mM NaCl, 25 mM MgCl2, 25% DMSO, 0.02%
Triton X-100, 0.1 mgÆmL)1 of N-acetylmuramidase from
Streptomyces globisporus (Calbiochem, San Diego, CA,
USA). In addition to the Triton X-100 brought with the
enzyme (0.02%), added detergent concentrations were:
0.02% DDM, 1% b-OG, 0.02% Triton X-100, 1% Chaps,
3% Cymal-3, 0.8% Cymal-4, 0.25% Cymal-5, which are
about twofold their CMCs. Time courses at 30 C were ini-
tiated with the addition of PBP2a or PBP2a* (1 lM), or
E. coli PBP1b (0.1 lM).
For the determination of kinetic parameters, measure-
ments were made with 5 and 10 lM lysine-dansylated lipid II,
in 50 mM Hepes, pH 7.5, 200 mM NaCl, 25 mMMgCl2, 25%
DMSO, 0.04% Triton X-100, at 30 C. The amplitude of the
ﬂuorescence decrease (ﬂuorescence at time zero minus ﬂuo-
rescence at the reached plateau) was taken as representing
the complete conversion of dansylated lipid II into dansylted
disaccharide pentapeptide. The initial slope of the ﬂuorescent
decrease could then be interpreted as a rate of lipid II
consumption.
S2d thio-ester hydrolysis
Activity of the TP domain of PBP2a, PBP2a*, PBP2x,
periplasmic PBP2x and E. coli PBP1b was assayed by
measuring the hydrolysis of the S2d thio-ester analogue of
cell-wall stem peptides [41]. Reaction mixtures (500 lL
each) contained 52 mM potassium phosphate pH 7.0, 2 mM
S2d, 0.8 mM 4,4¢-dithiodipyridine and 3–5 lg of PBP. The
thio-group release that was coupled to 4,4¢-dithiodipyridine
was measured by monitoring the increase in absorption at
325 nm (molar extinction coefﬁcient e = 19 800 M)1Æcm)1)
for 3 min at 37 C as described [51]. Negative controls were
performed in the presence of 0.5 mM penicillin G.
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